Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors

被引:130
作者
Mukherjee, P [1 ]
Abate, LE [1 ]
Seyfried, TN [1 ]
机构
[1] Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA
关键词
D O I
10.1158/1078-0432.CCR-04-0308
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The antiangiogenic and proapoptotic mechanisms of dietary caloric restriction (DR) are unknown. In this study, we evaluated the effects of moderate (40%) DR on the orthotopic growth of mouse and human brain tumors that differ in cell origin, angiogenicity, host environment, and biochemical composition. Experimental Design: A malignant mouse astrocytoma (CT-2A) and a human glioma (U87-MG) were highly angiogenic and fast growing, whereas a mouse ependymoblastoma was less vascularized and slower growing. The tumors were evaluated for growth, cell proliferation, microvessel density, and apoptosis under DR and ad libitum feeding. Serum vascular endothelial growth factor and insulin-like growth factor I levels were examined as angiogenic biomarkers. Results: DR significantly decreased vascularity (factor VIII) and increased apoptosis (terminal deoxynucleotidyl transferase-mediated nick end labeling) in all tumors. These effects were associated with enhanced caspase-3 and poly(ADP-ribose) polymerase cleavage in the CT-2A and ependymoblastoma tumors, but not in the U87-MG tumor. DR also caused reductions of serum insulin-like growth factor I and glucose levels. Conclusions: DR had significant antiangiogenic and proapoptotic effects in the three distinct brain tumor models. DR, however, had differential effects on cell proliferation, biomarkers of angiogenesis, and apoptosis, suggesting multiple mechanisms of action. Because extensive angiogenesis and resistance to apoptosis are hallmarks of gliomas, this study provides new insight into the molecular basis of the DR-induced inhibition of brain tumor growth.
引用
收藏
页码:5622 / 5629
页数:8
相关论文
共 54 条
[1]   Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death [J].
Aft, RL ;
Zhang, FW ;
Gius, D .
BRITISH JOURNAL OF CANCER, 2002, 87 (07) :805-812
[2]  
Bai HW, 1997, J LIPID RES, V38, P160
[3]  
Bello L, 2001, CANCER RES, V61, P8730
[4]   EXPRESSION OF THE VASCULAR-PERMEABILITY FACTOR VASCULAR ENDOTHELIAL GROWTH-FACTOR GENE IN CENTRAL-NERVOUS-SYSTEM NEOPLASMS [J].
BERKMAN, RA ;
MERRILL, MJ ;
REINHOLD, WC ;
MONACCI, WT ;
SAXENA, A ;
CLARK, WC ;
ROBERTSON, JT ;
ALI, IU ;
OLDFIELD, EH .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (01) :153-159
[5]   Glucocorticoid mediation of dietary energy restriction inhibition of mouse skin carcinogenesis [J].
Birt, DF ;
Yaktine, A ;
Duysen, E .
JOURNAL OF NUTRITION, 1999, 129 (02) :571S-574S
[6]   Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis - Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells [J].
Boulares, AH ;
Yakovlev, AG ;
Ivanova, V ;
Stoica, BA ;
Wang, GP ;
Iyer, S ;
Smulson, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (33) :22932-22940
[7]   Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas [J].
Chaudhry, IH ;
O'Donovan, DG ;
Brenchley, PEC ;
Reid, H ;
Roberts, ISD .
HISTOPATHOLOGY, 2001, 39 (04) :409-415
[8]   Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor [J].
Cheng, SY ;
Huang, HJS ;
Nagane, M ;
Ji, XD ;
Wang, DG ;
Shih, CCY ;
Arap, W ;
Huang, CM ;
Cavenee, WK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (16) :8502-8507
[9]  
Christov C, 1998, NEUROPATH APPL NEURO, V24, P29
[10]   THE INFLUENCE OF IMUVERT, A BIOLOGICAL RESPONSE MODIFIER, ON THE GROWTH AND GANGLIOSIDE COMPOSITION OF MURINE NEURAL TUMORS [J].
COTTERCHIO, M ;
SEYFRIED, TN .
MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1993, 20 (02) :163-172